
Episode 15: Not just a party drug: MDMA therapy for people with PTSD
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
このコンテンツについて
This podcast discusses the carefully controlled clinical use of MDMA in a therapeutic research setting with specially trained professionals. MDMA remains a class A illegal drug and recreational use can carry significant legal and health risks. Please do not try this at home.
Recent research has found that MDMA-assisted therapy is a safe and effective intervention for severe post-traumatic stress disorder (PSTD), but it remains a heavily restricted drug. Dr Mat Hoskins hopes that his research carried out in Cardiff and other studies across Europe will improve the quality of the research investigating this novel treatment approach.
We were thrilled to sit down with Mat to understand what led him to this type of research, why does it work, and what does a session actually involve.
Dr Mat Hoskins is the Lead Consultant Psychiatrist for adults at Traumatic Stress Wales. He also works as a Psychiatric Intensive Care Consultant and has experience using Trauma Focused Psychological Therapies.
Traumatic Stress Wales (TSW) is funded by Welsh Government and aims to improve the health and wellbeing of people of all ages living in Wales at risk of developing or with post-traumatic stress disorder (PTSD) or complex post-traumatic stress disorder (CPTSD). Visit the Traumatic Stress Wales website.
Join our research community
At NCMH, we are fortunate to collaborate with TSW through our Traumatic Stress Research Group. If you're interested in joining our research community and hearing about the research projects that are available to get involved in, you can sign-up on our NCMH website.
Hosted on Acast. See acast.com/privacy for more information.